Editorial inquiries

What we can respond to

Retatrutide Telehealth Digest is an editorial project. We welcome:

• Corrections — If you have identified a factual error, an outdated citation, or a claim that does not match its source, please describe it specifically. We will review and update.
• Citation suggestions — If a relevant peer-reviewed study is missing from the research record we've documented, we'd like to know.
• Editorial feedback — Questions about framing, editorial decisions, or how we characterize the research record.

We review all submissions and update content when corrections are warranted. We do not guarantee a response to every inquiry.

What we cannot respond to

We are not a medical service. We are not clinicians. We cannot and do not:

• Advise on whether retatrutide is appropriate for any individual.
• Recommend sources, vendors, or suppliers.
• Answer questions about dosing, reconstitution, or self-administration.
• Provide medical referrals.
• Respond to inquiries that presuppose we offer a healthcare or telehealth service.

If you need medical guidance, consult a licensed healthcare provider.

Contact form

Use the form below for editorial inquiries. Provide as much specific context as possible — vague feedback is difficult to act on.

Subject [text field] Message [textarea] Your email (optional) [email field]

[Submit]

Retatrutide Telehealth Digest is an editorial project summarizing peer-reviewed research. It is not a clinic, pharmacy, telehealth provider, or vendor. No medical advice is provided through this form or anywhere on this site.